{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Human thymidine phosphorylase", "Privileged scaffolds", "Structure-based drug design", "Virtual screening"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29853339", "DateCompleted": {"Year": "2018", "Month": "11", "Day": "14"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "26"}], "Language": ["eng"], "ELocationID": ["10.1016/j.bmc.2018.05.046", "S0968-0896(18)30380-8"], "Journal": {"ISSN": "1464-3391", "JournalIssue": {"Volume": "26", "Issue": "12", "PubDate": {"Year": "2018", "Month": "Jul", "Day": "23"}}, "Title": "Bioorganic & medicinal chemistry", "ISOAbbreviation": "Bioorg Med Chem"}, "ArticleTitle": "Rational design of bis-indolylmethane-oxadiazole hybrids as inhibitors of thymidine phosphorylase.", "Pagination": {"StartPage": "3654", "EndPage": "3663", "MedlinePgn": "3654-3663"}, "Abstract": {"AbstractText": ["Inhibition of Thymidine phosphorylase (TP) is continuously studied for the design and development of new drugs for the treatment of neoplastic diseases. As a part of our effort to identify TP inhibitors, we performed a structure-based virtual screening (SBVS) of our compound collection. Based on the insights gained from structures of virtual screening hits, a scaffold was designed using 1,3,4-oxadiazole as the basic structural feature and SAR studies were carried out for the optimization of this scaffold. Twenty-five novel bis-indole linked 1,3,4-oxadiazoles (7-31) were designed, synthesized and tested in vitro against E. coli TP (EcTP). Compound 7 emerged as potent TP inhibitor with an IC<sub>50</sub> value of 3.50\u202f\u00b1\u202f0.01\u202f\u03bcM. Docking studies were carried out using GOLD software on thymidine phosphorylase from human (hTP) and E. coli (EcTP). Various hydrogen bonding, hydrophobic interactions, and \u03c0-\u03c0 stacking were observed between designed molecules and the active site amino acid residues of the studied enzymes."], "CopyrightInformation": "Copyright \u00a9 2018 Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam 31441, Saudi Arabia. Electronic address: mtaha@iau.edu.sa."}], "LastName": "Taha", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, COMSATS University Islamabad, Abbottbad Campus 22060, Pakistan."}], "LastName": "Rashid", "ForeName": "Umer", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA, Puncak Alam 40450, Malaysia; Faculty of Applied Sciences, Universiti Teknologi MARA, Shah Alam 42300, Malaysia."}], "LastName": "Imran", "ForeName": "Syahrul", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "UoN Chair of Oman's Medicinal Plants and Marine Natural Products, University of Nizwa, P.O. Box 33, Birkat Al Mauz, Nizwa 616, Oman."}], "LastName": "Ali", "ForeName": "Muhammad", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Bioorg Med Chem", "NlmUniqueID": "9413298", "ISSNLinking": "0968-0896"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxadiazoles"}, {"RegistryNumber": "EC 2.4.2.4", "NameOfSubstance": "Thymidine Phosphorylase"}, {"RegistryNumber": "OP0UW79H66", "NameOfSubstance": "Methane"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": [], "DescriptorName": "Catalytic Domain"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["enzymology"], "DescriptorName": "Escherichia coli"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hydrogen Bonding"}, {"QualifierName": ["chemistry"], "DescriptorName": "Methane"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Oxadiazoles"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Thymidine Phosphorylase"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "2", "Day": "22"}, {"Year": "2018", "Month": "4", "Day": "29"}, {"Year": "2018", "Month": "5", "Day": "26"}, {"Year": "2018", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "11", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29853339", "10.1016/j.bmc.2018.05.046", "S0968-0896(18)30380-8"]}}]}